Home > News > Nanogen Shares Nosedive as Q2 Loss Nearly Doubles
August 4th, 2004
Nanogen Shares Nosedive as Q2 Loss Nearly Doubles
Nanogen Inc., maker of the NanoChip molecular diagnostics system for biologic research, saw its stock drop nearly 21 percent today after posting a second-quarter loss that almost doubled its loss of a year ago. Nanogen shares (Nasdaq: NGEN) fell 99 cents, or 20.6 percent, to close at $3.81 today. The firm has a market cap of $97.65 million.
Aspen Aerogels, Inc. Schedules Second Quarter 2014 Earnings Release and Conference Call July 15th, 2014
Nanometrics to Announce Second Quarter Financial Results on July 30, 2014 July 9th, 2014
Small, but heading for the big time: Nanobiotix revenue for the 1st quarter of 2014 and new composition of the shareholding May 12th, 2014
Harris & Harris Group Reports Financial Statements as of March 31, 2014 May 8th, 2014